MRI developer Bruker has appointed Anthony Mattacchione as its chief financial officer (CFO), effective immediately.
Mattacchione has served as the company's interim CFO since June 2015, and he previously served as Bruker's senior vice president of finance and accounting.
Mattacchione brings more than 30 years of financial, accounting, operational, and management experience to Bruker. Prior to becoming Bruker's interim CFO, he had responsibility for the company's global finance and accounting functions, including financial planning and analysis, corporate accounting, public company reporting, treasury, tax, shared financial services, internal controls and audit, and global enterprise resource planning business processes.
Prior to joining Bruker, Mattacchione served as CFO of EMD Millipore, a subsidiary of Merck, from 2010 to 2013. Before that, he was vice president, controller, and chief accounting officer of Millipore between 2006 and 2010. He also held various financial leadership roles during a 16-year career at Gerber Scientific. Mattacchione is a certified public accountant and holds a Master of Business Administration from the University of Connecticut.
